Overview

CIS001 Extension Study of Cyclosporine Inhalation Solution

Status:
Terminated

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

This trial is a longterm follow up of a phase III study of inhaled cyclosporine for the prevention of chronic rejection in lung transplant recipients.

Phase:

Phase 3

Details

Lead Sponsor:

APT Pharmaceuticals, Inc.

Treatments:

Cyclosporine
Cyclosporins
Pharmaceutical Solutions